Efficacy and Safety of Botulinum Toxin Type A in Treating Patients of Advanced Age with Idiopathic Trigeminal Neuralgia

OBJECTIVE: To assess the therapeutic efficacy and safety of botulinum toxin type A (BTX-A) for treating idiopathic trigeminal neuralgia (ITN) in patients ≥80 years old. METHODS: Selected patients (n=43) with ITN, recruited from the neurology clinic and inpatient department of the Second Affiliated H...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jing, Xu, Ying-Ying, Zhang, Qi-Lin, Luo, Wei-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907496/
https://www.ncbi.nlm.nih.gov/pubmed/29849847
http://dx.doi.org/10.1155/2018/7365148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907496/
https://www.ncbi.nlm.nih.gov/pubmed/29849847
http://dx.doi.org/10.1155/2018/7365148

Ejemplares similares